Literature DB >> 17285752

Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.

Manjusha Malhotra1, Dipak K Majumdar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17285752      PMCID: PMC2750333          DOI: 10.1208/pt070496

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


× No keyword cloud information.
  21 in total

1.  In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note.

Authors:  Manjusha Malhotra; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2005-10-24       Impact factor: 3.246

2.  Corneal ulceration and the serum antiproteases. I. Alpha 1-antitrypsin.

Authors:  M B Berman; J C Barber; R C Talamo; C E Langley
Journal:  Invest Ophthalmol       Date:  1973-10

3.  The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.

Authors:  A J Flach; M C Kraff; D R Sanders; L Tanenbaum
Journal:  Arch Ophthalmol       Date:  1988-04

4.  Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits.

Authors:  E B Fraser-Smith; T R Matthews
Journal:  J Ocul Pharmacol       Date:  1988

5.  Antiproteolytic activities found in human tears.

Authors:  J A Anderson; I H Leopold
Journal:  Ophthalmology       Date:  1981-01       Impact factor: 12.079

6.  The role of arachidonic acid metabolites in the mediation of the polymorphonuclear leukocyte response following corneal injury.

Authors:  B D Srinivasan; P S Kulkarni
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-09       Impact factor: 4.799

7.  The analgesic and anti-inflammatory profile of (+/-)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid (RS-37619).

Authors:  W H Rooks; A J Tomolonis; P J Maloney; M B Wallach; M E Schuler
Journal:  Agents Actions       Date:  1982-12

Review 8.  Prostaglandin and non-prostaglandin mediated breeakdown of the blood-aqueous barrier.

Authors:  K E Eakins
Journal:  Exp Eye Res       Date:  1977       Impact factor: 3.467

9.  Effect of LTD4 on conjunctival vasopermeability and blood-aqueous barrier integrity.

Authors:  D F Woodward; S E Ledgard
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-04       Impact factor: 4.799

10.  Inflammatory responses of the rabbit eye to prostaglandins.

Authors:  D W Hall; K D Jaitly
Journal:  Agents Actions Suppl       Date:  1977
View more
  3 in total

1.  Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.

Authors:  Mona Hassan Aburahma; Azza Ahmed Mahmoud
Journal:  AAPS PharmSciTech       Date:  2011-10-07       Impact factor: 3.246

Review 2.  Topical ocular delivery of NSAIDs.

Authors:  Munish Ahuja; Avinash S Dhake; Surendra K Sharma; Dipak K Majumdar
Journal:  AAPS J       Date:  2008-04-25       Impact factor: 4.009

3.  Effects of topical flurbiprofen sodium, diclofenac sodium, ketorolac tromethamine and benzalkonium chloride on corneal sensitivity in normal dogs.

Authors:  Raquel de Araújo Cantarella; Juliana Kravetz de Oliveira; Daniel M Dorbandt; Fabiano Montiani-Ferreira
Journal:  Open Vet J       Date:  2017-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.